PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Gross Margin (2010 - 2012)

Updated

PharmaCyte Biotech (PMCB) recorded Gross Margin of 20.89% in FY2013 (year ended Apr 30, 2013), down 49.99 percentage points from 70.88% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) Gross Margin (2010 - 2012) Analysis & Trends

  • Per Business Quant data, PMCB's Gross Margin was 70.88% in FY2012 (-3.64 pp) and 74.52% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -53.01%
Jul 31, 2012 100.00%
Apr 30, 2012 167.94%
Jan 31, 2012 89.09%
Oct 31, 2011 69.58%
Jul 31, 2011 20.68%
Apr 30, 2011 99.33%
Jan 31, 2011 31.36%
Oct 31, 2010 82.02%
Jul 31, 2010 74.31%
API Access

PharmaCyte Biotech Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY